APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Hypoglycemic Agents

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oral Hypoglycemic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025195 pages

Choose your research edition.

Industry ResearchOral Hypoglycemic Agents Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Hypoglycemic Agents Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Oral Hypoglycemic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Hypoglycemic Agents Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Hypoglycemic Agents Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Oral Hypoglycemic Agents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Oral Hypoglycemic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Hypoglycemic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Hypoglycemic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oral Hypoglycemic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Hypoglycemic Agents include Janssen Pharmaceuticals, Abbott Laboratories, Takeda, Sanofi S.A., Novartis International AG, Merk and Co., Eli Lilly and Company, Pfizer Inc and Beohringer Ingelgeim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Oral Hypoglycemic Agents market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Hypoglycemic Agents and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Hypoglycemic Agents revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Oral Hypoglycemic Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Hypoglycemic Agents Segment by Company

Janssen Pharmaceuticals

Abbott Laboratories

Takeda

Sanofi S.A.

Novartis International AG

Merk and Co.

Eli Lilly and Company

Pfizer Inc

Beohringer Ingelgeim

Bristol Myers Squibb

Biocon Limited

Astellas Pharma Inc.

AstraZeneca plc

Oral Hypoglycemic Agents Segment by Type

Capsule

Tablet

Liquid

Oral Hypoglycemic Agents Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Oral Hypoglycemic Agents Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Hypoglycemic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Hypoglycemic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Hypoglycemic Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Oral Hypoglycemic Agents in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Hypoglycemic Agents industry.

Chapter 3: Detailed analysis of Oral Hypoglycemic Agents companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Hypoglycemic Agentsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oral Hypoglycemic Agents Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Capsule Table 3. Key Players of Tablet Table 4. Key Players of Liquid Table 4. Global Oral Hypoglycemic Agents Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Retail Pharmacies Table 6. Key Players of Online Pharmacies Table 7. Key Players of Hospital Pharmacies Table 8. Global Oral Hypoglycemic Agents Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Oral Hypoglycemic Agents Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Oral Hypoglycemic Agents Market Share by Region (2021-2026) Table 11. Global Oral Hypoglycemic Agents Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Oral Hypoglycemic Agents Market Share by Region (2027-2032) Table 13. Oral Hypoglycemic Agents Industry Trends Table 14. Oral Hypoglycemic Agents Industry Drivers Table 15. Oral Hypoglycemic Agents Industry Opportunities and Challenges Table 16. Oral Hypoglycemic Agents Industry Restraints Table 17. Global Oral Hypoglycemic Agents Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Oral Hypoglycemic Agents Revenue Market Share by Company (2021-2026) Table 19. Global Oral Hypoglycemic Agents Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Oral Hypoglycemic Agents Key Company Head Office and Area Served Table 21. Global Oral Hypoglycemic Agents Company, Product Type & Application Table 22. Global Oral Hypoglycemic Agents Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Oral Hypoglycemic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Oral Hypoglycemic Agents Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Oral Hypoglycemic Agents Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Oral Hypoglycemic Agents Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Oral Hypoglycemic Agents Revenue Market Share by Type (2021-2026) Table 29. Global Oral Hypoglycemic Agents Revenue Market Share by Type (2027-2032) Table 30. Global Oral Hypoglycemic Agents Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Oral Hypoglycemic Agents Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Oral Hypoglycemic Agents Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Oral Hypoglycemic Agents Revenue Market Share by Application (2021-2026) Table 34. Global Oral Hypoglycemic Agents Revenue Market Share by Application (2027-2032) Table 35. Janssen Pharmaceuticals Company Information Table 36. Janssen Pharmaceuticals Business Overview Table 37. Janssen Pharmaceuticals Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Janssen Pharmaceuticals Oral Hypoglycemic Agents Product Portfolio Table 39. Janssen Pharmaceuticals Recent Development Table 40. Abbott Laboratories Company Information Table 41. Abbott Laboratories Business Overview Table 42. Abbott Laboratories Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Abbott Laboratories Oral Hypoglycemic Agents Product Portfolio Table 44. Abbott Laboratories Recent Development Table 45. Takeda Company Information Table 46. Takeda Business Overview Table 47. Takeda Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Takeda Oral Hypoglycemic Agents Product Portfolio Table 49. Takeda Recent Development Table 50. Sanofi S.A. Company Information Table 51. Sanofi S.A. Business Overview Table 52. Sanofi S.A. Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Sanofi S.A. Oral Hypoglycemic Agents Product Portfolio Table 54. Sanofi S.A. Recent Development Table 55. Novartis International AG Company Information Table 56. Novartis International AG Business Overview Table 57. Novartis International AG Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Novartis International AG Oral Hypoglycemic Agents Product Portfolio Table 59. Novartis International AG Recent Development Table 60. Merk and Co. Company Information Table 61. Merk and Co. Business Overview Table 62. Merk and Co. Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Merk and Co. Oral Hypoglycemic Agents Product Portfolio Table 64. Merk and Co. Recent Development Table 65. Eli Lilly and Company Company Information Table 66. Eli Lilly and Company Business Overview Table 67. Eli Lilly and Company Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Eli Lilly and Company Oral Hypoglycemic Agents Product Portfolio Table 69. Eli Lilly and Company Recent Development Table 70. Pfizer Inc Company Information Table 71. Pfizer Inc Business Overview Table 72. Pfizer Inc Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Pfizer Inc Oral Hypoglycemic Agents Product Portfolio Table 74. Pfizer Inc Recent Development Table 75. Beohringer Ingelgeim Company Information Table 76. Beohringer Ingelgeim Business Overview Table 77. Beohringer Ingelgeim Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Beohringer Ingelgeim Oral Hypoglycemic Agents Product Portfolio Table 79. Beohringer Ingelgeim Recent Development Table 80. Bristol Myers Squibb Company Information Table 81. Bristol Myers Squibb Business Overview Table 82. Bristol Myers Squibb Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Bristol Myers Squibb Oral Hypoglycemic Agents Product Portfolio Table 84. Bristol Myers Squibb Recent Development Table 85. Biocon Limited Company Information Table 86. Biocon Limited Business Overview Table 87. Biocon Limited Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Biocon Limited Oral Hypoglycemic Agents Product Portfolio Table 89. Biocon Limited Recent Development Table 90. Astellas Pharma Inc. Company Information Table 91. Astellas Pharma Inc. Business Overview Table 92. Astellas Pharma Inc. Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Astellas Pharma Inc. Oral Hypoglycemic Agents Product Portfolio Table 94. Astellas Pharma Inc. Recent Development Table 95. AstraZeneca plc Company Information Table 96. AstraZeneca plc Business Overview Table 97. AstraZeneca plc Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. AstraZeneca plc Oral Hypoglycemic Agents Product Portfolio Table 99. AstraZeneca plc Recent Development Table 100. North America Oral Hypoglycemic Agents Market Size by Type (2021-2026) & (US$ Million) Table 101. North America Oral Hypoglycemic Agents Market Size by Type (2027-2032) & (US$ Million) Table 102. North America Oral Hypoglycemic Agents Market Size by Application (2021-2026) & (US$ Million) Table 103. North America Oral Hypoglycemic Agents Market Size by Application (2027-2032) & (US$ Million) Table 104. North America Oral Hypoglycemic Agents Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Oral Hypoglycemic Agents Market Size by Country (2021-2026) Table 106. North America Oral Hypoglycemic Agents Market Size by Country (2027-2032) Table 107. Europe Oral Hypoglycemic Agents Market Size by Type (2021-2026) & (US$ Million) Table 108. Europe Oral Hypoglycemic Agents Market Size by Type (2027-2032) & (US$ Million) Table 109. Europe Oral Hypoglycemic Agents Market Size by Application (2021-2026) & (US$ Million) Table 110. Europe Oral Hypoglycemic Agents Market Size by Application (2027-2032) & (US$ Million) Table 111. Europe Oral Hypoglycemic Agents Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Oral Hypoglycemic Agents Market Size by Country (2021-2026) Table 113. Europe Oral Hypoglycemic Agents Market Size by Country (2027-2032) Table 114. China Oral Hypoglycemic Agents Market Size by Type (2021-2026) & (US$ Million) Table 115. China Oral Hypoglycemic Agents Market Size by Type (2027-2032) & (US$ Million) Table 116. China Oral Hypoglycemic Agents Market Size by Application (2021-2026) & (US$ Million) Table 117. China Oral Hypoglycemic Agents Market Size by Application (2027-2032) & (US$ Million) Table 118. Asia Oral Hypoglycemic Agents Market Size by Type (2021-2026) & (US$ Million) Table 119. Asia Oral Hypoglycemic Agents Market Size by Type (2027-2032) & (US$ Million) Table 120. Asia Oral Hypoglycemic Agents Market Size by Application (2021-2026) & (US$ Million) Table 121. Asia Oral Hypoglycemic Agents Market Size by Application (2027-2032) & (US$ Million) Table 122. Asia Oral Hypoglycemic Agents Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Asia Oral Hypoglycemic Agents Market Size by Country (2021-2026) Table 124. Asia Oral Hypoglycemic Agents Market Size by Country (2027-2032) Table 125. South America, Middle East & Africa Oral Hypoglycemic Agents Market Size by Type (2021-2026) & (US$ Million) Table 126. South America, Middle East & Africa Oral Hypoglycemic Agents Market Size by Type (2027-2032) & (US$ Million) Table 127. South America, Middle East & Africa Oral Hypoglycemic Agents Market Size by Application (2021-2026) & (US$ Million) Table 128. South America, Middle East & Africa Oral Hypoglycemic Agents Market Size by Application (2027-2032) & (US$ Million) Table 129. South America, Middle East & Africa Oral Hypoglycemic Agents Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. South America, Middle East & Africa Oral Hypoglycemic Agents Market Size by Country (2021-2026) Table 131. South America, Middle East & Africa Oral Hypoglycemic Agents Market Size by Country (2027-2032) Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Oral Hypoglycemic Agents Product Image Figure 2. Global Oral Hypoglycemic Agents Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Oral Hypoglycemic Agents Market Share by Type: 2025 VS 2032 Figure 4. Capsule Image Figure 5. Tablet Image Figure 6. Liquid Image Figure 7. Global Oral Hypoglycemic Agents Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Oral Hypoglycemic Agents Market Share by Application: 2025 VS 2032 Figure 9. Retail Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Hospital Pharmacies Image Figure 12. Global Oral Hypoglycemic Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 14. Global Oral Hypoglycemic Agents Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Oral Hypoglycemic Agents Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Oral Hypoglycemic Agents Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Oral Hypoglycemic Agents Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Oral Hypoglycemic Agents Revenue Market Share by Type (2021-2032) Figure 21. Global Oral Hypoglycemic Agents Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Oral Hypoglycemic Agents Revenue Market Share by Application (2021-2032) Figure 23. North America Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 24. North America Oral Hypoglycemic Agents Market Share by Type (2021-2032) Figure 25. North America Oral Hypoglycemic Agents Market Share by Application (2021-2032) Figure 26. North America Oral Hypoglycemic Agents Market Share by Country (2021-2032) Figure 27. United States Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 28. Canada Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 30. Europe Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 31. Europe Oral Hypoglycemic Agents Market Share by Type (2021-2032) Figure 32. Europe Oral Hypoglycemic Agents Market Share by Application (2021-2032) Figure 33. Europe Oral Hypoglycemic Agents Market Share by Country (2021-2032) Figure 34. Germany Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 35. France Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 37. Italy Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 38. Russia Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 40. China Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 41. China Oral Hypoglycemic Agents Market Share by Type (2021-2032) Figure 42. China Oral Hypoglycemic Agents Market Share by Application (2021-2032) Figure 43. Asia Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 44. Asia Oral Hypoglycemic Agents Market Share by Type (2021-2032) Figure 45. Asia Oral Hypoglycemic Agents Market Share by Application (2021-2032) Figure 46. Asia Oral Hypoglycemic Agents Market Share by Country (2021-2032) Figure 47. Japan Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 51. India Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 52. Australia Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Oral Hypoglycemic Agents Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Oral Hypoglycemic Agents Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Oral Hypoglycemic Agents Market Share by Country (2021-2032) Figure 57. Brazil Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 62. UAE Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 64. Chile Oral Hypoglycemic Agents Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Tablet
  • Liquid
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Janssen Pharmaceuticals
  • Abbott Laboratories
  • Takeda
  • Sanofi S.A.
  • Novartis International AG
  • Merk and Co.
  • Eli Lilly and Company
  • Pfizer Inc
  • Beohringer Ingelgeim
  • Bristol Myers Squibb
  • Biocon Limited
  • Astellas Pharma Inc.
  • AstraZeneca plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Oral Hypoglycemic Agents Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Capsule
  5. 1.2.3 Tablet
  6. 1.2.4 Liquid
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Oral Hypoglycemic Agents Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Retail Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Hospital Pharmacies
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Oral Hypoglycemic Agents Growth Trends by Region
  14. 1.5.1 Global Oral Hypoglycemic Agents Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Oral Hypoglycemic Agents Market Size by Region (2021-2026)
  16. 1.5.3 Oral Hypoglycemic Agents Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Oral Hypoglycemic Agents Market Dynamics
  1. 2.1 Oral Hypoglycemic Agents Industry Trends
  2. 2.2 Oral Hypoglycemic Agents Industry Drivers
  3. 2.3 Oral Hypoglycemic Agents Industry Opportunities and Challenges
  4. 2.4 Oral Hypoglycemic Agents Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Oral Hypoglycemic Agents Revenue by Company (2021-2026)
  2. 3.2 Global Oral Hypoglycemic Agents Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Oral Hypoglycemic Agents Key Company Head office and Area Served
  4. 3.4 Global Oral Hypoglycemic Agents Company, Product Type & Application
  5. 3.5 Global Oral Hypoglycemic Agents Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Oral Hypoglycemic Agents Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Oral Hypoglycemic Agents Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Oral Hypoglycemic Agents Tier 1, Tier 2, and Tier 3
4 Oral Hypoglycemic Agents Market by Type
  1. 4.1 Global Oral Hypoglycemic Agents Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Oral Hypoglycemic Agents Market Size by Type (2021-2032)
  3. 4.3 Global Oral Hypoglycemic Agents Market Size Share by Type (2021-2032)
5 Oral Hypoglycemic Agents Market by Application
  1. 5.1 Global Oral Hypoglycemic Agents Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Oral Hypoglycemic Agents Market Size by Application (2021-2032)
  3. 5.3 Global Oral Hypoglycemic Agents Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Janssen Pharmaceuticals
  2. 6.1.1 Janssen Pharmaceuticals Company Information
  3. 6.1.2 Janssen Pharmaceuticals Business Overview
  4. 6.1.3 Janssen Pharmaceuticals Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Janssen Pharmaceuticals Oral Hypoglycemic Agents Product Portfolio
  6. 6.1.5 Janssen Pharmaceuticals Recent Developments
  7. 6.2 Abbott Laboratories
  8. 6.2.1 Abbott Laboratories Company Information
  9. 6.2.2 Abbott Laboratories Business Overview
  10. 6.2.3 Abbott Laboratories Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Abbott Laboratories Oral Hypoglycemic Agents Product Portfolio
  12. 6.2.5 Abbott Laboratories Recent Developments
  13. 6.3 Takeda
  14. 6.3.1 Takeda Company Information
  15. 6.3.2 Takeda Business Overview
  16. 6.3.3 Takeda Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Takeda Oral Hypoglycemic Agents Product Portfolio
  18. 6.3.5 Takeda Recent Developments
  19. 6.4 Sanofi S.A.
  20. 6.4.1 Sanofi S.A. Company Information
  21. 6.4.2 Sanofi S.A. Business Overview
  22. 6.4.3 Sanofi S.A. Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sanofi S.A. Oral Hypoglycemic Agents Product Portfolio
  24. 6.4.5 Sanofi S.A. Recent Developments
  25. 6.5 Novartis International AG
  26. 6.5.1 Novartis International AG Company Information
  27. 6.5.2 Novartis International AG Business Overview
  28. 6.5.3 Novartis International AG Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Novartis International AG Oral Hypoglycemic Agents Product Portfolio
  30. 6.5.5 Novartis International AG Recent Developments
  31. 6.6 Merk and Co.
  32. 6.6.1 Merk and Co. Company Information
  33. 6.6.2 Merk and Co. Business Overview
  34. 6.6.3 Merk and Co. Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Merk and Co. Oral Hypoglycemic Agents Product Portfolio
  36. 6.6.5 Merk and Co. Recent Developments
  37. 6.7 Eli Lilly and Company
  38. 6.7.1 Eli Lilly and Company Company Information
  39. 6.7.2 Eli Lilly and Company Business Overview
  40. 6.7.3 Eli Lilly and Company Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Eli Lilly and Company Oral Hypoglycemic Agents Product Portfolio
  42. 6.7.5 Eli Lilly and Company Recent Developments
  43. 6.8 Pfizer Inc
  44. 6.8.1 Pfizer Inc Company Information
  45. 6.8.2 Pfizer Inc Business Overview
  46. 6.8.3 Pfizer Inc Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Pfizer Inc Oral Hypoglycemic Agents Product Portfolio
  48. 6.8.5 Pfizer Inc Recent Developments
  49. 6.9 Beohringer Ingelgeim
  50. 6.9.1 Beohringer Ingelgeim Company Information
  51. 6.9.2 Beohringer Ingelgeim Business Overview
  52. 6.9.3 Beohringer Ingelgeim Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Beohringer Ingelgeim Oral Hypoglycemic Agents Product Portfolio
  54. 6.9.5 Beohringer Ingelgeim Recent Developments
  55. 6.10 Bristol Myers Squibb
  56. 6.10.1 Bristol Myers Squibb Company Information
  57. 6.10.2 Bristol Myers Squibb Business Overview
  58. 6.10.3 Bristol Myers Squibb Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Bristol Myers Squibb Oral Hypoglycemic Agents Product Portfolio
  60. 6.10.5 Bristol Myers Squibb Recent Developments
  61. 6.11 Biocon Limited
  62. 6.11.1 Biocon Limited Company Information
  63. 6.11.2 Biocon Limited Business Overview
  64. 6.11.3 Biocon Limited Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Biocon Limited Oral Hypoglycemic Agents Product Portfolio
  66. 6.11.5 Biocon Limited Recent Developments
  67. 6.12 Astellas Pharma Inc.
  68. 6.12.1 Astellas Pharma Inc. Company Information
  69. 6.12.2 Astellas Pharma Inc. Business Overview
  70. 6.12.3 Astellas Pharma Inc. Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Astellas Pharma Inc. Oral Hypoglycemic Agents Product Portfolio
  72. 6.12.5 Astellas Pharma Inc. Recent Developments
  73. 6.13 AstraZeneca plc
  74. 6.13.1 AstraZeneca plc Company Information
  75. 6.13.2 AstraZeneca plc Business Overview
  76. 6.13.3 AstraZeneca plc Oral Hypoglycemic Agents Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 AstraZeneca plc Oral Hypoglycemic Agents Product Portfolio
  78. 6.13.5 AstraZeneca plc Recent Developments
7 North America
  1. 7.1 North America Oral Hypoglycemic Agents Market Size (2021-2032)
  2. 7.2 North America Oral Hypoglycemic Agents Market Size by Type
  3. 7.2.1 North America Oral Hypoglycemic Agents Market Size by Type (2021-2026)
  4. 7.2.2 North America Oral Hypoglycemic Agents Market Size by Type (2027-2032)
  5. 7.2.3 North America Oral Hypoglycemic Agents Market Share by Type (2021-2032)
  6. 7.3 North America Oral Hypoglycemic Agents Market Size by Application
  7. 7.3.1 North America Oral Hypoglycemic Agents Market Size by Application (2021-2026)
  8. 7.3.2 North America Oral Hypoglycemic Agents Market Size by Application (2027-2032)
  9. 7.3.3 North America Oral Hypoglycemic Agents Market Share by Application (2021-2032)
  10. 7.4 North America Oral Hypoglycemic Agents Market Size by Country
  11. 7.4.1 North America Oral Hypoglycemic Agents Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Oral Hypoglycemic Agents Market Size by Country (2021-2026)
  13. 7.4.3 North America Oral Hypoglycemic Agents Market Size by Country (2027-2032)
  14. 7.4.4 North America Oral Hypoglycemic Agents Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Oral Hypoglycemic Agents Market Size (2021-2032)
  2. 8.2 Europe Oral Hypoglycemic Agents Market Size by Type
  3. 8.2.1 Europe Oral Hypoglycemic Agents Market Size by Type (2021-2026)
  4. 8.2.2 Europe Oral Hypoglycemic Agents Market Size by Type (2027-2032)
  5. 8.2.3 Europe Oral Hypoglycemic Agents Market Share by Type (2021-2032)
  6. 8.3 Europe Oral Hypoglycemic Agents Market Size by Application
  7. 8.3.1 Europe Oral Hypoglycemic Agents Market Size by Application (2021-2026)
  8. 8.3.2 Europe Oral Hypoglycemic Agents Market Size by Application (2027-2032)
  9. 8.3.3 Europe Oral Hypoglycemic Agents Market Share by Application (2021-2032)
  10. 8.4 Europe Oral Hypoglycemic Agents Market Size by Country
  11. 8.4.1 Europe Oral Hypoglycemic Agents Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Oral Hypoglycemic Agents Market Size by Country (2021-2026)
  13. 8.4.3 Europe Oral Hypoglycemic Agents Market Size by Country (2027-2032)
  14. 8.4.4 Europe Oral Hypoglycemic Agents Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Oral Hypoglycemic Agents Market Size (2021-2032)
  2. 9.2 China Oral Hypoglycemic Agents Market Size by Type
  3. 9.2.1 China Oral Hypoglycemic Agents Market Size by Type (2021-2026)
  4. 9.2.2 China Oral Hypoglycemic Agents Market Size by Type (2027-2032)
  5. 9.2.3 China Oral Hypoglycemic Agents Market Share by Type (2021-2032)
  6. 9.3 China Oral Hypoglycemic Agents Market Size by Application
  7. 9.3.1 China Oral Hypoglycemic Agents Market Size by Application (2021-2026)
  8. 9.3.2 China Oral Hypoglycemic Agents Market Size by Application (2027-2032)
  9. 9.3.3 China Oral Hypoglycemic Agents Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Oral Hypoglycemic Agents Market Size (2021-2032)
  2. 10.2 Asia Oral Hypoglycemic Agents Market Size by Type
  3. 10.2.1 Asia Oral Hypoglycemic Agents Market Size by Type (2021-2026)
  4. 10.2.2 Asia Oral Hypoglycemic Agents Market Size by Type (2027-2032)
  5. 10.2.3 Asia Oral Hypoglycemic Agents Market Share by Type (2021-2032)
  6. 10.3 Asia Oral Hypoglycemic Agents Market Size by Application
  7. 10.3.1 Asia Oral Hypoglycemic Agents Market Size by Application (2021-2026)
  8. 10.3.2 Asia Oral Hypoglycemic Agents Market Size by Application (2027-2032)
  9. 10.3.3 Asia Oral Hypoglycemic Agents Market Share by Application (2021-2032)
  10. 10.4 Asia Oral Hypoglycemic Agents Market Size by Country
  11. 10.4.1 Asia Oral Hypoglycemic Agents Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Oral Hypoglycemic Agents Market Size by Country (2021-2026)
  13. 10.4.3 Asia Oral Hypoglycemic Agents Market Size by Country (2027-2032)
  14. 10.4.4 Asia Oral Hypoglycemic Agents Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Oral Hypoglycemic Agents Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Oral Hypoglycemic Agents Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Oral Hypoglycemic Agents Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Oral Hypoglycemic Agents Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Oral Hypoglycemic Agents Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Oral Hypoglycemic Agents Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Oral Hypoglycemic Agents Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Oral Hypoglycemic Agents Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Oral Hypoglycemic Agents Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Oral Hypoglycemic Agents Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Oral Hypoglycemic Agents Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Oral Hypoglycemic Agents Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Oral Hypoglycemic Agents Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Oral Hypoglycemic Agents Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst